Gunnar Juliusson

Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Wolfgang Knauf, Toshko Lissichkov, Ali Aldaoud et al. · Journal of Clinical Oncology · 2009 · 436 citations · Full text

Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome

Jeanette Lundin, Hans Hagberg, Roland Repp et al. · Blood · 2003 · 389 citations · Full text

Recurrent mutations refine prognosis in chronic lymphocytic leukemia

Panagiotis Baliakas, Anastasia Hadzidimitriou, L-A Sutton et al. · Leukemia · 2014 · 273 citations

Hematological Malignancy, Tumor Biology, Recurrent Mutations +7

Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma

Gunnar Juliusson, Fredrik Celsing, Ingemar Turesson et al. · British Journal of Haematology · 2000 · 245 citations · Full text

Hematological Malignancy, Best Response, Health Sciences +15

Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

Peter Gimsing, Kristina Carlson, Ingemar Turesson et al. · The Lancet Oncology · 2010 · 117 citations · Full text

Bone Disease, Hematological Malignancy, Bone Health +8